Recombinant Methanococcus maripaludis Cobalt transport protein CbiN (cbiN)

Shipped with Ice Packs
In Stock

Description

Functional Role in Cobalt Transport

CbiN operates as part of an ABC transporter complex (CbiN-O-M), where it binds extracellular cobalt and transfers it to the transmembrane subunits (CbiO-M). This mechanism aligns with the general ABC transporter paradigm:

  1. Substrate Capture: CbiN adopts a closed conformation upon cobalt binding, stabilizing the substrate in a high-affinity state .

  2. ATP Hydrolysis: The nucleotide-binding domains (NBDs) of the transporter hydrolyze ATP, driving conformational changes that translocate cobalt across the membrane .

Cobalt is essential for methanogenesis, as it serves as a cofactor in enzymes like methyl-coenzyme M reductase (Mcr) .

Recombinant Production and Handling

Commercially available recombinant CbiN is produced in E. coli and purified via affinity chromatography. Key specifications include:

ParameterDetailsSource
FormLyophilized powder in Tris/PBS buffer with 6% trehalose, pH 8.0
ReconstitutionRecommended in deionized water (0.1–1.0 mg/mL) with 5–50% glycerol
Storage-20°C/-80°C (long-term); 4°C for working aliquots (up to 1 week)
Pricing~$1,360 (MyBioSource) or ~€1,437 (Creative Biomart) for 50 µg

Research Applications

CbiN is utilized in biochemical and structural studies to investigate ABC transporter mechanisms. Notable applications include:

  • Biochemical Assays: ELISA kits (e.g., CSB-CF389453MNP) enable quantification of CbiN in experimental samples, aiding studies on transporter regulation .

  • Structural Biology: Crystallographic studies of related ABC transporters (e.g., Archaeoglobus fulgidus ModBC) provide insights into substrate recognition and ATP-dependent conformational changes .

Comparative Analysis of Variants

The two recombinant CbiN variants differ in sequence and gene locus:

FeatureVariant A4FW42 (MmarC5_0096)Variant A9A9I2 (MmarC6_1192)
AA SequenceILILAPLIMYS...IGAIIIGYFFILTLAPLIMYS...IGAMIIGYFF
C-terminal MotifEDKNDDKN
AccessionA4FW42A9A9I2

These differences may influence substrate affinity or binding kinetics, though experimental validation is required .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement. We will accommodate your requests whenever possible.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please contact your local distributor for specific delivery information.
Note: All protein shipments default to standard blue ice packs. If dry ice shipping is required, please inform us in advance. Additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents are settled at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol final concentration is 50% and can be used as a reference.
Shelf Life
The shelf life is influenced by various factors including storage conditions, buffer ingredients, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot the product for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
cbiN; MmarC5_0096; Cobalt transport protein CbiN; Energy-coupling factor transporter probable substrate-capture protein CbiN
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-97
Protein Length
full length protein
Species
Methanococcus maripaludis (strain C5 / ATCC BAA-1333)
Target Names
cbiN
Target Protein Sequence
MEFKHVLMILGVIILILAPLIMYSGLGEDEGYFGGADGAAGDLIMEISPNYEPWFEPFWE PPSGEIESLLFALQAAIGAIIIGYFFGYNKAKYEDKN
Uniprot No.

Target Background

Function
CbiN is part of the energy-coupling factor (ECF) transporter complex CbiMNOQ, which is involved in cobalt import.
Database Links
Protein Families
CbiN family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is CbiN and what role does it play in M. maripaludis?

CbiN is a cobalt transport protein in Methanococcus maripaludis that plays a crucial role in cobalt uptake, which is essential for vitamin B12 biosynthesis and methanogenic metabolism. The protein consists of 97 amino acids with the sequence: MEFKHVLMILGVIILILAPLIMYSGLGEDEGYFGGADGAAGDLIMEISPNYEPWFEPFWEPPSGEIESLLFALQAAIGAIIIGYFFGYNKAKYEDKN . As a transmembrane protein, CbiN functions as part of a larger cobalt transport complex that facilitates the selective uptake of cobalt ions across the cell membrane. This process is vital for the archaeon's survival in environments where cobalt availability may be limited.

How is recombinant CbiN protein typically produced?

Recombinant CbiN protein production follows standard recombinant protein expression protocols with specific optimizations for archaeal proteins. The process involves:

  • DNA cloning: The cbiN gene is isolated and inserted into an expression vector at a specific location using restriction enzymes .

  • Transformation: The recombinant DNA molecule containing the cbiN gene is introduced into host cells, typically E. coli for ease of manipulation and high yield potential .

  • Selection and expression: Transformed cells are selected using antibiotic resistance markers incorporated in the vector. Only cells that have successfully integrated the recombinant DNA will survive in the presence of the specific antibiotic .

  • Protein production: The host cells express the recombinant CbiN protein through transcription and translation of the inserted gene .

  • Purification: The expressed protein is typically fused with a His-tag to facilitate purification using affinity chromatography methods .

This expression in E. coli rather than the native archaeon allows for higher yield and easier manipulation of growth conditions.

What are the recommended storage conditions for recombinant CbiN protein?

For optimal stability and activity, recombinant CbiN protein should be stored following these guidelines:

  • Store the lyophilized powder at -20°C/-80°C upon receipt .

  • Aliquoting is necessary to prevent protein degradation during repeated freeze-thaw cycles .

  • Working aliquots can be stored at 4°C for up to one week .

  • Repeated freezing and thawing should be avoided as it can lead to protein denaturation and loss of functionality .

Proper storage is critical for maintaining protein structure and function, especially for transmembrane proteins like CbiN that may be prone to aggregation when removed from their native membrane environment.

How can CRISPR/Cas12a technology be applied to study CbiN function in M. maripaludis?

CRISPR/Cas12a technology offers a powerful approach for investigating CbiN function through precise genetic manipulation. The methodology involves:

  • Design of guide RNA (gRNA): Specific gRNAs targeting the cbiN gene or its regulatory regions should be designed with consideration of M. maripaludis genome characteristics.

  • Vector construction: The gRNA and Cas12a gene can be expressed using a vector like pMM002P, which has been successfully used in M. maripaludis .

  • Transformation: Introduction of the CRISPR/Cas12a system into M. maripaludis using appropriate transformation protocols.

  • Homology-directed repair: For gene editing, homology arms of 500-1000 bp should be provided to direct the repair of Cas12a-induced double-strand breaks . This is particularly important as M. maripaludis lacks efficient non-homologous end-joining (NHEJ) machinery .

  • Selection and verification: Transformed cells can be selected, and genome editing can be verified using restriction digestion of PCR products or sequencing .

When implementing this approach, researchers should be aware that M. maripaludis has an active PstI restriction modification system that can digest foreign DNA containing unmethylated PstI sites, potentially reducing transformation efficiency by 1.6-3.4 fold per PstI site .

What expression systems are most effective for functional studies of CbiN?

The choice of expression system significantly impacts the functional studies of CbiN. Here's a methodological comparison:

Expression SystemAdvantagesLimitationsRecommended Applications
E. coliHigh yield, ease of manipulation, well-established protocolsPotential improper folding of archaeal proteins, lack of archaeal-specific modificationsInitial structural studies, antibody production
Native M. maripaludisAuthentic protein folding and modifications, natural membrane environmentLower yield, more complex cultivation conditionsFunctional assays, interaction studies
Cell-free systemsRapid expression, avoids toxicity issuesMay lack proper membrane environment for transmembrane proteinsPreliminary functional screening

For promoter selection in M. maripaludis, several options have been evaluated with different strengths:

  • Strong constitutive promoters: Pmcr, Pmcr_JJ, Pfla_JJ, PglnA, and Pmtr show strong expression under various growth conditions .

  • Substrate-dependent promoters: PhdrC1 shows expression only in formate-containing media, offering a conditional expression option .

  • Regulated promoters: Pnif is normally repressed by nitrogen regulatory protein R, providing an option for controlled expression .

The selection of an appropriate promoter should be based on the specific requirements of the experimental design, including the desired expression level and timing.

What experimental approaches can determine CbiN's role in cobalt transport and vitamin B12 synthesis?

To elucidate CbiN's functional role, a multi-faceted experimental approach is recommended:

  • Knockout/knockdown studies: Generate cbiN deletion mutants using CRISPR/Cas12a genome editing and assess:

    • Growth rates in cobalt-limited media

    • Vitamin B12 production levels

    • Cobalt uptake rates using radioactive 60Co

  • Complementation assays: Reintroduce wild-type or mutant cbiN genes to knockout strains to verify phenotype restoration.

  • Protein-protein interaction studies:

    • Co-immunoprecipitation to identify binding partners

    • Bacterial two-hybrid assays to confirm direct interactions

    • Crosslinking experiments to capture transient interactions

  • Transport assays:

    • Membrane vesicle preparations with reconstituted CbiN

    • Measurement of cobalt uptake under various conditions

    • Competition assays with other divalent metals

  • Structural studies:

    • Circular dichroism to assess secondary structure

    • X-ray crystallography or cryo-EM for detailed structural information

These approaches should be implemented systematically, with appropriate controls to account for the polyploid nature of M. maripaludis and potential pleiotropic effects of cbiN manipulation.

How should researchers design experiments to measure CbiN-mediated cobalt transport?

Designing robust experiments to measure CbiN-mediated cobalt transport requires careful consideration of several methodological aspects:

  • Preparation of experimental system:

    • Purify recombinant CbiN with intact structural integrity

    • Reconstitute CbiN in liposomes or proteoliposomes

    • Prepare membrane vesicles from CbiN-expressing cells

  • Transport assay setup:

    • Establish baseline conditions: optimal pH, temperature, and ionic strength

    • Prepare radioactive 60Co or fluorescent cobalt probes

    • Set up appropriate negative controls (liposomes without CbiN, inactive CbiN mutants)

  • Measurement parameters:

    • Design time-course measurements to determine transport kinetics

    • Establish concentration gradients to determine Km and Vmax values

    • Include competition assays with other divalent cations (Ni2+, Zn2+, Fe2+)

  • Data collection and analysis:

    • Record quantitative data with appropriate replicates (n≥3)

    • Use statistical methods to determine significance (t-tests for paired comparisons)

    • For quantitative data, calculate range and standard deviation

    • Prepare properly labeled tables with units and significant figures

  • Validation approaches:

    • Confirm CbiN-dependency through selective inhibition

    • Verify results using genetic approaches (cbiN knockout/complementation)

    • Perform control experiments with related transport proteins

This experimental design allows for rigorous quantification of CbiN-mediated cobalt transport while controlling for potential confounding factors.

What statistical approaches are most appropriate for analyzing CbiN functional data?

  • For comparing transport rates between conditions:

    • Two-sided t-test for paired comparisons (e.g., wild-type vs. mutant)

    • ANOVA for multiple condition comparisons, followed by post-hoc tests (Tukey's HSD)

    • Non-parametric alternatives (Mann-Whitney U test, Kruskal-Wallis) if data doesn't meet normality assumptions

  • For kinetic data analysis:

    • Non-linear regression for determining Michaelis-Menten parameters

    • Lineweaver-Burk or Eadie-Hofstee transformations for visualizing kinetic data

    • Bootstrap resampling for robust parameter estimation

  • For dose-response relationships:

    • Hill equation fitting for cooperative binding

    • IC50 determination for inhibition studies

    • Curve comparison tests to evaluate differences between conditions

  • For presenting variation in data:

    • Range and standard deviation for quantitative measurements

    • Frequency tables or histograms for qualitative data

    • Error bars representing standard error of the mean or confidence intervals

  • For multivariate analysis:

    • Principal component analysis for identifying patterns in complex datasets

    • Cluster analysis for grouping similar experimental conditions

    • Machine learning approaches for predictive modeling of transport activity

When reporting results, include measures of central tendency (mean) and measures of variation (range or standard deviation), as appropriate for the experimental design .

How can researchers address the polyploid nature of M. maripaludis when studying CbiN function?

M. maripaludis, like many archaea, possesses multiple genome copies (polyploidy), which presents unique challenges for genetic studies of CbiN. Researchers should implement these methodological approaches:

  • Complete genome editing verification:

    • Use restriction digestion analysis with engineered restriction sites (e.g., NotI) to distinguish between wild-type and edited genome copies

    • Perform quantitative PCR to determine the ratio of wild-type to modified genome copies

    • Implement serial passages with selection to enrich for cells with complete genome modification

  • Phenotypic analysis strategies:

    • Establish dose-response relationships between the proportion of modified genomes and observed phenotypes

    • Use conditional expression systems to overcome partial modification challenges

    • Implement single-cell analysis techniques to correlate genotype with phenotype

  • Data analysis considerations:

    • Account for heterogeneity in cell populations when interpreting bulk measurements

    • Develop mathematical models that incorporate varying levels of gene expression

    • Use appropriate statistical methods that account for increased variability

This methodological framework enables researchers to navigate the complexities of polyploidy when investigating CbiN function in M. maripaludis.

How can researchers distinguish between direct and indirect effects in CbiN knockout studies?

Distinguishing direct from indirect effects in CbiN knockout studies requires a systematic approach:

  • Complementation analysis:

    • Reintroduce wild-type cbiN on a plasmid under native or controlled promoters

    • Create point mutations in functional domains to identify specific requirements

    • Implement dose-dependent expression systems to establish causality

  • Temporal analysis:

    • Use time-course experiments to identify primary (immediate) versus secondary effects

    • Implement pulse-chase experiments with radioactive cobalt to track transport kinetics

    • Analyze gene expression changes over time after CbiN depletion

  • Metabolomic profiling:

    • Compare metabolite profiles between wild-type and cbiN mutants

    • Focus on vitamin B12-dependent pathways and cobalt-utilizing enzymes

    • Track isotopically labeled cobalt through metabolic networks

  • Epistasis analysis:

    • Create double knockouts with genes in related pathways

    • Establish genetic interaction networks to position CbiN in cellular processes

    • Implement synthetic lethality screens to identify functional redundancies

  • Direct biochemical verification:

    • Reconstitute purified CbiN in artificial membrane systems

    • Perform in vitro transport assays under controlled conditions

    • Use structure-function analysis to validate specific transport mechanisms

This comprehensive approach helps delineate the direct role of CbiN in cobalt transport from secondary effects resulting from vitamin B12 deficiency or other metabolic perturbations.

How can CRISPR/Cas12a be optimized for efficient editing of cbiN in M. maripaludis?

Optimizing CRISPR/Cas12a for efficient editing of cbiN requires attention to several key parameters:

  • Guide RNA design optimization:

    • Select guide RNAs with minimal off-target potential in the M. maripaludis genome

    • Target PAM sites (TTTV for LbCas12a) that are accessible in the archaeal chromatin

    • Avoid regions with secondary structures that might impede Cas12a binding

  • Expression system considerations:

    • Select appropriate promoters for Cas12a and gRNA expression (e.g., Pmcr, Pmcr_JJ, or Pfla_JJ for strong constitutive expression)

    • Optimize codon usage for efficient translation in M. maripaludis

    • Use compatible selectable markers for transformation validation

  • Homology-directed repair optimization:

    • Design homology arms of 500-1000 bp, which have shown similar efficiency in M. maripaludis

    • Avoid PstI restriction sites in the homology arms to prevent digestion by the native restriction system

    • Include selectable markers or screenable phenotypes within the repair template

  • Transformation protocol refinements:

    • Optimize transformation conditions to maximize uptake of the CRISPR/Cas12a components

    • Consider methylation of the transformation DNA to protect against restriction

    • Implement recovery steps that allow for efficient homology-directed repair

  • Screening and validation:

    • Design PCR strategies to identify successful editing events

    • Implement restriction digestion screening (e.g., with engineered NotI sites)

    • Confirm edits by sequencing and functional assays

This optimized approach takes advantage of the CRISPR/Cas12a system's efficiency while addressing the specific challenges of genetic manipulation in M. maripaludis.

How can proteomics and transcriptomics enhance understanding of CbiN function?

Integrating proteomics and transcriptomics provides powerful insights into CbiN function:

  • Comparative transcriptomics approaches:

    • RNA-seq analysis of wild-type vs. cbiN knockout strains

    • Identification of differentially expressed genes in cobalt-limited conditions

    • Time-course analysis after cobalt addition or depletion

    • Correlation of expression patterns with vitamin B12-dependent pathways

  • Proteomics methodologies:

    • Quantitative proteomics (iTRAQ, TMT, or label-free) to identify protein abundance changes

    • Phosphoproteomics to detect signaling pathways affected by cobalt availability

    • Protein-protein interaction studies using proximity labeling (BioID, APEX)

    • Membrane proteomics to identify co-localized transport components

  • Integrative data analysis:

    • Correlation of transcriptomic and proteomic changes

    • Pathway enrichment analysis to identify affected cellular processes

    • Network analysis to position CbiN within the cobalt homeostasis network

    • Machine learning approaches to predict functional relationships

  • Validation experiments:

    • Targeted gene expression analysis by qRT-PCR

    • Western blotting for key proteins identified in -omics studies

    • Metabolic flux analysis to confirm functional consequences

This integrative approach provides a systems-level understanding of CbiN's role in cobalt transport and its impact on broader cellular metabolism, particularly vitamin B12-dependent processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.